Search results
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 7 days agoTwo of 2023’s largest acquisitions — Roche’s $7.1 billion acquisition of Telavant and Merck & Co.’s...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 6 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 7 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
Tango drops USP1 inhibitor over liver toxicity in patients during phase 1 trial
FierceBiotech· 5 days agoThe plan had been to add AstraZeneca’s and Merck & Co.’s PARP inhibitor Lynparza into the mix as a...
HPV vaccine can have big health benefits for men, research shows
Morningstar· 3 days agoA vaccine that's widely known to help protect women from cervical cancer can also offer significant health benefits for men, new research shows. Human papillomavirus vaccination is linked with ...
STOCKS OF LOCAL INTEREST
Clinton Herald, Iowa· 7 days agoMay 20—Adv Auto Parts 72.67 Abbott Labs 103.21 ADM 60.87 Ameriprise 433.10 AutoZone, Inc. 2,924.04 Boeing 186.61 Bank of America 38.82 BP PLC ADR 37.26 ConAgra Foods 30.71 Caterpillar 363.01 ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoGlobal Antibiotics Market Projected to Reach $49.6 Billion by 2027 PR Newswire BOSTON, May 22, 2024 Global Antibiotics Market, as forecasted by BCC Research, to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through 2027 BOSTON, May 22, 2024
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 5 days agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit
Fortune· 4 days agoJurors on Thursday found that GSK and Boehringer weren’t liable for Angela Valadez’s injuries and that the companies had properly marketed the drug without a warning about its alleged cancer ...
